🔴 Wave Life Sciences is trading 5.4% down today after a wider-than-expected Q2 loss and revenue miss

Wave Life Sciences is trading 5.4% down at $5.73 after reporting a wider-than-expected second-quarter loss and a sharp revenue decline compared to the previous year.

• The company posted Q2 revenue of $2.3 million, down from $8.7 million last year, and a net loss of $69.4 million, or ($0.34) per share, missing analyst estimates.
• Despite the negative price action, management highlighted significant pipeline progress and a cash runway that extends into Q3 2028.